By Professor Jason Grebely

Journal articles

Mallise C; Tremain D; Lindsay M; Ryder N; Fisher K; Moran B; Lecathelinais C; Mesure J; Grebely J; Marshall A; Dunlop A; Woodward S; Byaruhanga J; Tyne J; Slater A; Kingsland M, 2025, 'Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs: A five-year retrospective program evaluation', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104868

Treloar C; Grebely J, 2025, 'Editorial - Supporting the best quality science and the rights of people who use drugs regardless of global policy changes: Perspectives from the co-Editors in Chief of the International Journal of Drug Policy', International Journal of Drug Policy, 142, http://dx.doi.org/10.1016/j.drugpo.2025.104836

Lafferty L; Brown T; McGrath C; Wright T; Henderson C; Lloyd AR; Grebely J; Treloar C, 2025, 'Implications of the fragility of opioid agonist treatment continuity on hepatitis C re-exposure concerns among people in prison: a qualitative study', International Journal of Drug Policy, 142, pp. 104831 - 104831, http://dx.doi.org/10.1016/j.drugpo.2025.104831

Conway A; Marshall AD; Grebely J; Fontaine G; Treloar C, 2025, 'Professional identities and new technologies of hepatitis C point-of-care testing', Social Science and Medicine, 378, http://dx.doi.org/10.1016/j.socscimed.2025.118140

Price O; Webb P; Grebely J; Peacock A; Medland N; Read P; Cooke E; Hickman M; Vickerman P; Degenhardt L, 2025, 'Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review', Drug and Alcohol Dependence, 273, http://dx.doi.org/10.1016/j.drugalcdep.2025.112732

Burton-McKeich GK; Lafferty L; Treloar C; Markus C; Matthews S; Applegate TL; Causer L; Grebely J; Marshall AD, 2025, '“It's not just running the test”: Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in Australia', International Journal of Drug Policy, 140, pp. 104800, http://dx.doi.org/10.1016/j.drugpo.2025.104800

Fontaine G; Taylor N; Bruneau J; Kronfli N; Greenaway C; Biondi MJ; Klein MB; Saeed S; Grebely J; Presseau J, 2025, 'The urgent need for implementation science to achieve hepatitis C elimination', Lancet Gastroenterology and Hepatology, 10, pp. 498 - 502, http://dx.doi.org/10.1016/S2468-1253(25)00050-0

Babor TF; Adinoff B; Clark L; Crockford D; Demetrovics Z; Dietze P; Fallu J-S; Gainsbury S; Gilchrist G; Gorelick DA; Graham K; Grebely J; Heim D; Hellman M; Laslett A-M; McCuistian C; Miovsky M; Morojele NK; Moskalewicz J; Obot IS; Pates R; Room R; Rychert M; Sultan A; Treloar C; Turner NE; Wells S; Williams EC; Witkiewitz K, 2025, 'A clarion call to the addiction science community: It's time to resist the anti-scientific policies of the US Trump administration.', J Behav Addict, http://dx.doi.org/10.1556/2006.2025.00033

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Babor TF; Adinoff B; Clark L; Crockford D; Demetrovics Z; Dietze P; Fallu JS; Gainsbury S; Gilchrist G; Gorelick DA; Graham K; Heim D; Hellman M; Laslett AM; McCuistian C; Miovsky M; Morojele NK; Moskalewicz J; Obot IS; Pates R; Room R; Rychert M; Sultan A; Treloar C; Turner NE; Wells S; Williams EC; Witkiewitz K; Grebely J, 2025, 'A clarion call to the addiction science community: It's time to resist the anti-scientific policies of the US Trump administration', NAD Nordic Studies on Alcohol and Drugs, 42, pp. 107 - 112, http://dx.doi.org/10.1177/14550725251325970

Artenie A; Trickey A; Looker KJ; Stone J; Lim AG; Fraser H; Degenhardt L; Dore GJ; Grebely J; Cunningham EB; Hazarizadeh B; Low-Beer D; Luhmann N; Webb P; Hickman M; Vickerman P, 2025, 'Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis', Lancet Gastroenterology and Hepatology, 10, pp. 315 - 331, http://dx.doi.org/10.1016/S2468-1253(24)00442-4

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Stevens A; Lafferty L; Treloar C; Cunningham EB; Dore GJ; Grebely J; Marshall AD, 2025, 'Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection', International Journal of Drug Policy, 137, pp. 104720 - 104720, http://dx.doi.org/10.1016/j.drugpo.2025.104720

Hiebert-Suwondo L; Manning J; Tohme RA; Buti M; Kondili LA; Spearman CW; Prabdial-Sing N; Turnier V; Lazarus JV; Waked I; Ward JW; Miranda A; Sugiyama A; Hajarizadeh B; Varaldo C; Thomas C; Muñoz C; Leeman D; Dore G; Desalegn H; Aberra H; Cheinquer H; Qureshi H; Ivanchuk I; Grebely J; García-Samaniego J; Tanaka J; Tint KS; Poovorawan K; De Feo ME; Sonderup M; Aleksandrova M; Ali M; Hassany M; Marinho R; Hamid S; Punpetch S; Naing TS; Tanaka-Kumadai Y; Lim YS; Nartey Y, 2025, 'A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles', The Lancet Gastroenterology and Hepatology, http://dx.doi.org/10.1016/S2468-1253(25)00069-X

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson S-A; Dore GJ, 2025, 'Missed Opportunities in HCV Care: Trends in Late Diagnosis and Treatment☆', JHEP Reports, pp. 101474 - 101474, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

Carrington N; Conway A; Grebely J; Starr M; Catlett B; Stevens A; Prain B; McGrath C; Causer L; Guy R; Holden J; Keen P; Kingsland M; Lu H; Power C; Read P; Murray C; McNulty A; Cunningham P, 2024, 'Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-08989-8

Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Tillakeratne S; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Cock V; Burns C; Henderson C; Christmass M; Dore GJ; Grebely J, 2024, 'A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study', Viruses, 16, http://dx.doi.org/10.3390/v16111763

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Grebely J, 2024, 'Point-of-Care Testing for Hepatitis C Infection: A Critical Building Block for the Foundation to Achieve Elimination', Clinical Infectious Diseases, 79, pp. 974 - 977, http://dx.doi.org/10.1093/cid/ciae156

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Macdonald C; Macpherson G; Leppan O; Tran LT; Cunningham EB; Hajarizadeh B; Grebely J; Farrell M; Altice FL; Degenhardt L, 2024, 'Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis', Lancet Public Health, 9, pp. e684 - e699, http://dx.doi.org/10.1016/S2468-2667(24)00160-9

Sheehan Y; Cochrane A; Treloar C; Grebely J; Tedla N; Lloyd AR; Lafferty L, 2024, 'Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104516

Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C, 2024, 'Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104477

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688

Wu HJ; Applegate TL; Kwon JA; Cunningham EB; Grebely J; Gray RT; Shih STF, 2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', Lancet Regional Health Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101119

Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468

Webb P; Ireland J; Colledge-Frisby S; Peacock A; Leung J; Vickerman P; Farrell M; Hickman M; Grebely J; Degenhardt L, 2024, 'Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104455

Levinsson A; Zolopa C; Vakili F; Udhesister S; Kronfli N; Maheu-Giroux M; Bruneau J; Valerio H; Bajis S; Read P; Martró E; Boucher L; Morris L; Grebely J; Artenie A; Stone J; Vickerman P; Larney S, 2024, 'Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis', Eclinicalmedicine, 72, http://dx.doi.org/10.1016/j.eclinm.2024.102596

Grebely J; Treloar C, 2024, 'Where to next for the international journal of drug policy: A continued focus on multidisciplinary research, community involvement, and impact', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104447

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, 43, pp. 997 - 1012, http://dx.doi.org/10.1111/dar.13823

Wu HJ; Shih STF; Applegate TL; Kwon JA; Cunningham EB; Grebely J; Gray RT, 2024, 'Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26251

Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828

Price O; Swanton R; Grebely J; Hajarizadeh B; Webb P; Peacock A; Dore GJ; Cowie BC; Vickerman P; Degenhardt L, 2024, 'Vaccination coverage among people who inject drugs: A systematic review', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104382

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Cooke GS; Flower B; Cunningham E; Marshall AD; Lazarus JV; Palayew A; Jia J; Aggarwal R; Al-Mahtab M; Tanaka Y; Jeong SH; Poovorawan K; Waked I; Hiebert L; Khue PM; Grebely J; Alcantara-Payawal D; Sanchez-Avila JF; Mbendi C; Muljono DH; Lesi O; Desalegn H; Hamid S; de Araujo A; Cheinquer H; Onyekwere CA; Malyuta R; Ivanchuk I; Thomas DL; Pimenov N; Chulanov V; Dirac MA; Han H; Ward JW, 2024, 'Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update', Lancet Gastroenterology and Hepatology, 9, pp. 346 - 365, http://dx.doi.org/10.1016/S2468-1253(23)00321-7

Sheehan Y; Grebely J; Lloyd AR, 2024, 'Reply to: “ ‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issues”', Journal of Hepatology, 80, pp. e107 - e108, http://dx.doi.org/10.1016/j.jhep.2023.10.020

Cheng Q; Valerio H; Cunningham EB; Shih STF; Silk D; Conway A; Treloar C; Murray C; Henderson C; Amin J; Read P; Dore GJ; Grebely J; Bath N; Milat A; Dunlop A; Holden J; Leadbeatter K; Day E; Habraken N; Dawson O; Degenhardt L; Scott C; Tillakeratne S; Marks P; Jayasinghe I; Martinez M; Reid H; Gleeson V; Van Dyk J; Mercade GE; Marshall AD; Obeid S; Wheeler A; Hooshyar SH; Catlett B; Verich A; Erratt A; Wheeler A; Ezard N; Reid D; Gorton C; Hayllar J; Lam T; Datta P; Wade A; Spruce S; Cock V; Cornwell M; Zohrab K; Christmass M; Connelly C; Cooper A; Montebello M; Cherry R; Dyer J; Arawal S; Press E; Horasak N; Lewis R; Carthew A; Morris D; Donohue K; Griffiths K; Lana JD; Shin S; Graf C; Hampson A; Qian S; Brown D; Lautier A; Curran C; Burns C; Raidu R; Stolzenhein K; Brabender W; Somes K; Abram N; Turne R; Larter S; Goodberg F; Luksza J; Hall M; Hazelwood S; Ismay C; McClurg B; Mincham C; Barlow K; Hoskins A; Salisbury K; Markham J; Talmet J; Dunn S; Mitchell A; McKinnon A; Smyth F; Snell L; Laing E; Clark M; Dorigo J, 2024, 'Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study', Value in Health, 27, pp. 216 - 225, http://dx.doi.org/10.1016/j.jval.2023.10.013

Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, pp. ofad637, http://dx.doi.org/10.1093/ofid/ofad637

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2024, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895

Rance J; Grebely J; Treloar C, 2024, 'The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs', Health Sociology Review, 33, pp. 104 - 118, http://dx.doi.org/10.1080/14461242.2024.2315031

Grebely J; Matthews S; Causer LM; Feld JJ; Cunningham P; Dore GJ; Applegate TL, 2024, 'We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?', Expert Review of Molecular Diagnostics, 24, pp. 177 - 191, http://dx.doi.org/10.1080/14737159.2023.2292645

Conway A; Marshall AD; Crawford S; Hayllar J; Grebely J; Treloar C, 2023, 'Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study', Implementation Science, 18, http://dx.doi.org/10.1186/s13012-023-01281-4

Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Bonn M; Wheeler A; Grebely J; Farrell M; Hickman M; Hayward A; Degenhardt L, 2023, 'Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104218

Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J, 2023, 'Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e1885 - e1898, http://dx.doi.org/10.1016/S2214-109X(23)00461-8

Back to profile page